Skip to main content
WeightCited

Chromium 用于 Insulin Resistance

B

Meta-analysis of 25 RCTs found significant improvements in fasting glucose (1.16 mmol/L) in type 2 diabetics. Chromium enhances insulin receptor substrate phosphorylation. The ADA notes insufficient evidence for routine recommendation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dchromium\u0026condition\u003Dinsulin\u002Dresistance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
结论

            
            
Meta-analysis of 25 RCTs found significant improvements in fasting glucose (1.16 mmol/L) in type 2 diabetics. Chromium enhances insulin receptor substrate phosphorylation. The ADA notes insufficient evidence for routine recommendation.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
25

        
研究数量

    

    

        
2000

        
受试者

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
等级

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
常用剂量

                

                    
                    

                        
general:

                        
25-35 mcg/day (AI)

                    

                    
                    

                        
weightmanagement:

                        
200-1,000 mcg/day chromium picolinate

                    

                    
                    

                        
insulinsensitivity:

                        
500-1,000 mcg/day

                    

                    
                

                
                

                    上限： No established UL; long-term safety data at >1,000 mcg/day limited
                

                
            

            

            

            
            

                最佳服用时间： With meals
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
已报告的副作用

                    
    
                        
                        
  • 
                            ⚠
                            Headache
                        
    • 
                        
                        
  • 
                            ⚠
                            Insomnia
                        
    • 
                        
                        
  • 
                            ⚠
                            Mood changes
                        
    • 
                        
                        
  • 
                            ⚠
                            GI discomfort
                        
    • 
                        
                    

                

                

                
                

                    
已知相互作用

                    
    
                        
                        
  • 
                            ●
                            Diabetes medications (may potentiate — hypoglycemia risk)
                        
    • 
                        
                        
  • 
                            ●
                            Insulin
                        
    • 
                        
                        
  • 
                            ●
                            Sulfonylureas
                        
    • 
                        
                        
  • 
                            ●
                            Levothyroxine (reduced absorption)
                        
    • 
                        
                    

                

                

                
                

                    

                        可耐受最高摄入量： No established UL; long-term safety data at >1,000 mcg/day limited
                    

                

                
            

            

                在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Chromium help with Insulin Resistance?
            
        
        

            Based on 25 studies with 2,000 participants, there is moderate evidence from clinical studies that Chromium may support Insulin Resistance management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much Chromium should I take for Insulin Resistance?
            
        
        

            Studies have used various dosages. A commonly studied range is 25-35 mcg/day (AI). Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Chromium?
            
        
        

            Reported side effects may include Headache, Insomnia, Mood changes, GI discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Chromium and Insulin Resistance?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 25 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
                
                
            

        

        

    


    
    












    

        FDA 免责声明:
        这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。